Clinical Trial Update: Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the optimal duration of antibiotic therapy for infective exacerbations in cystic fibrosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Imperial College London | Conditions: Cystic Fibrosis | Phase 4 | Status: UNKNOWN